Top Sens. Target Drug Cos.' Pay-For-Delay Deals

Law360, New York (February 4, 2009, 12:00 AM EST) -- Two influential U.S. senators have introduced legislation that would outlaw what they call anti-competitive payments made by brand-name pharmaceutical companies to generics makers that resolve patent fights by delaying the availability of less-expensive generic drugs.

On Tuesday, senior Senate Judiciary Committee members Herb Kohl, D-Wisc., and Chuck Grassley, R-Iowa, unveiled the pay-for-delay measure, which is opposed by brand-name drugmakers but has won the support of President Obama in the past.

"With this legislation, we can end a practice seriously impeding generic-drug competition — competition that could...
To view the full article, register now.